The complete GLP-1 support stack — week by week

Why most GLP-1 supplement advice is wrong

The supplement industry moved fast when semaglutide prescriptions hit eight figures. Within months of Ozempic going mainstream, dozens of companies launched “GLP-1 support stacks” — bundles of 8 to 12 supplements promising to optimize your results, protect your muscle, fix your hair, and supercharge fat loss. Most of these stacks share three problems that make them actively counterproductive for someone starting GLP-1 therapy.

Problem one: they front-load everything. A typical commercial GLP-1 stack tells you to start taking creatine, HMB, magnesium, zinc, a multivitamin, omega-3s, collagen, vitamin D, a probiotic, and a greens powder — all on day one. This is a bad plan. Your body is adjusting to a new medication that fundamentally changes how your stomach empties, how your brain processes hunger signals, and how your GI tract moves food. The nausea, the bloating, the constipation — these are real and expected during the first weeks. Dropping a dozen new supplements into that environment guarantees you won’t know which one is helping, which one is making things worse, and which ones aren’t doing anything at all. If your stomach rebels on day four, was it the dose titration, the creatine, the magnesium citrate, or the greens powder? You’ll never know, and you’ll probably quit all of them.

Problem two: they ignore the phases. Weeks one through four on a GLP-1 are physiologically different from months two through six, which are different from month six onward. Your supplement strategy should reflect that. The priorities during early titration (GI tolerance, establishing baseline habits) are fundamentally different from the priorities during peak weight loss (lean mass preservation, protein adequacy) and different again from long-term maintenance (sustainability, habit consolidation). A flat, unchanging supplement regimen treats a dynamic process as if it were static.

Problem three: they’re optimized for margin, not evidence. Collagen protein is one of the highest-margin supplements in the industry and one of the least useful for GLP-1 patients specifically. Same for BCAAs, same for “metabolism support” blends. The supplements with strong evidence for GLP-1 therapy — creatine monohydrate, HMB, magnesium glycinate — tend to be commodity products with low margins. That’s not a coincidence: things that have been studied extensively for decades tend to be cheap. The expensive, branded products tend to be the ones with the least evidence.

Then there’s the protein misconception. “Just eat more protein” is correct advice and simultaneously unhelpful for someone on a GLP-1. When your total caloric intake drops to 800–1,200 calories per day — and it will, especially in the first few months — hitting 130 grams of protein requires that roughly 40–65% of your total calories come from protein. That doesn’t happen by accident. It doesn’t happen by “trying to eat more chicken.” It happens through deliberate meal architecture: choosing foods specifically for their protein density per volume, timing meals around leucine thresholds, and in some cases supplementing with whey protein in liquid form because it’s the fastest way to get 30 grams of protein into a stomach that doesn’t want food.

The right approach is sequenced. Start with the highest-leverage interventions — the ones with strong evidence and low GI risk. Add complexity only when the simpler interventions are established and your body has adapted. Never introduce a new supplement during the same week you increase your GLP-1 dose. And be honest about what’s proven, what’s plausible, and what’s marketing.

Understanding the phases of GLP-1 therapy

GLP-1 titration isn’t a single event. It’s a progression through three distinct physiological states, each with different risks, different priorities, and different intervention strategies. The biggest mistake in supplement planning is treating all three phases the same.

Phase 1 — Titration (Weeks 1–8)

You’re starting at a sub-therapeutic dose and working up. For semaglutide, that’s 0.25mg for four weeks, then 0.5mg, with potential increases to 1.0mg, 1.7mg, and 2.4mg over subsequent months. Tirzepatide follows a similar escalation from 2.5mg upward.

During titration, your body is adapting to fundamentally altered gastric motility. Food stays in your stomach longer. Your brain is receiving satiety signals it didn’t receive before. GI symptoms — nausea, constipation, occasional diarrhea, bloating, acid reflux — are at their most intense and most unpredictable. Some weeks are fine. Some weeks are miserable. The pattern is rarely linear.

Appetite suppression is often strongest during titration, which creates a paradox: you’re eating the least at the point where your body hasn’t yet started losing significant lean mass. The weight loss in weeks one through four is modest — often 2–5% of body weight — and includes a meaningful water weight component.

Phase 1 priority stack: GI tolerance first. Protein preservation second. Everything else is noise.

Phase 2 — Maintenance dose (Months 2–6)

You’ve reached or are approaching your target dose. GI symptoms have usually stabilized — not disappeared, but become predictable. Your body has adapted to the new gastric emptying rate. You know which foods you tolerate and which ones trigger nausea.

This is the critical window. Weight loss is at its most aggressive. You’re losing 1–2% of body weight per month on average, and the body composition story matters enormously here. Without intervention, 35–40% of that weight loss is lean mass (Wilding et al., 2021, NEJM; Jastreboff et al., 2022, NEJM). That’s not a GLP-1-specific problem — it’s a caloric-restriction problem — but GLP-1s create a deeper and more sustained deficit than most people achieve through willpower alone, which amplifies the lean mass risk.

Protein targets are hardest to hit during Phase 2 because appetite suppression is fully engaged but weight loss is fastest. You need the most protein per calorie at the exact moment your body wants the fewest calories.

Phase 2 priority stack: Lean mass preservation first. Protein distribution second. GI support as needed.

Phase 3 — Long-term / plateau (Month 6+)

Weight loss decelerates. Some patients hit a true plateau. Others experience dose tolerance — the same dose produces less appetite suppression than it did at month three. Body composition outcomes from Phases 1 and 2 are largely baked in: if you preserved lean mass during the aggressive loss phase, you’re in a strong position. If you didn’t, rebuilding muscle in a caloric deficit is physiologically much harder than preserving it.

Phase 3 is about sustainability. Which of these habits will you maintain for years? Which supplements are genuinely worth the ongoing cost? For some patients, this is also the phase where they discuss dose reduction, cycling protocols, or discontinuation with their prescriber — and the habits and body composition you built in Phases 1–2 determine how well you maintain results.

Phase 3 priority stack: Sustainable habits first. Supplement optimization (keep what works, drop what doesn’t) second. Consider cycling or deloading protocols.

Weeks 1–2: The baseline stack

Start with two things. Not eight. Not twelve. Two. You can always add more. You can never un-introduce a supplement that caused a GI flare during the week you also increased your dose.

Creatine monohydrate — 5g daily

Creatine is the single most evidence-supported supplement for lean mass preservation, and the reason it belongs in Week 1 — before you’re losing meaningful weight — is saturation kinetics.

Creatine works by increasing intramuscular phosphocreatine stores. These stores don’t fill overnight. At a standard dose of 5g per day, full saturation takes approximately 3–4 weeks (Hultman et al., 1996, Journal of Applied Physiology). If you wait until Month 2 — when weight loss accelerates and lean mass risk peaks — you’re only half-saturated when you need full protection. The smart move is to start saturating from Week 1 so your muscles are fully loaded by the time the deficit deepens.

What saturation means in practice: Your muscles have a finite capacity to store phosphocreatine. At baseline (no supplementation), stores are roughly 60–80% of capacity. Supplementation fills the remaining 20–40%. This matters for two reasons: phosphocreatine directly supports short-duration, high-intensity muscle contractions (i.e., resistance training), and higher intramuscular creatine appears to have an independent anti-catabolic effect through cell volumization and mTOR pathway signaling (Safdar et al., 2008, PLOS One).

GI note: A subset of patients report mild GI discomfort from creatine during the first few days — bloating, mild nausea, or loose stools. This overlaps with GLP-1 titration symptoms, which makes attribution tricky. If you experience this, split the dose: 2.5g in the morning with food, 2.5g in the evening with food. This almost always resolves the issue. If it doesn’t resolve within 3–4 days, pause creatine for a week and retry after your GI symptoms from GLP-1 titration stabilize.

The creatinine conversation you need to have. This matters. Creatine is metabolized into creatinine, which is a waste product filtered by the kidneys. When you take exogenous creatine, your serum creatinine level rises — typically by 10–20% — because you’re producing more creatinine than baseline. This is not kidney damage. Your kidneys are functioning identically. But your next blood draw will show elevated creatinine, and the eGFR (estimated glomerular filtration rate) calculation uses serum creatinine as an input. Higher creatinine means a lower calculated eGFR, which can trigger a “kidney function concern” flag in your lab results.

The fix is simple: tell your prescriber before the blood draw, not after they call you concerned. Say: “I started creatine supplementation on [date]. My creatinine will be elevated due to increased creatinine production, not reduced clearance. You may want to note this when interpreting eGFR.” This saves everyone a stressful phone call and an unnecessary nephrology referral.

Dose: 3–5g daily. Five grams is the most-studied dose. Three grams works for smaller individuals and saturates more slowly (4–5 weeks instead of 3–4). No loading phase is required — loading (20g/day for 5–7 days, then 5g/day) achieves saturation faster but causes more GI distress, which is the last thing you need during GLP-1 titration. Monohydrate only. Creatine HCl, “buffered” creatine, creatine ethyl ester — none have demonstrated superiority to monohydrate in controlled trials, and most cost 3–5x more per gram.

Magnesium glycinate — 200–400mg elemental, before bed

Magnesium deficiency is endemic. An estimated 50% of the U.S. population consumes less than the estimated average requirement for magnesium (Rosanoff et al., 2012, Nutrition Reviews). GLP-1-induced caloric restriction makes this worse — when you’re eating 800–1,200 calories per day, your micronutrient intake from food drops proportionally. Magnesium is one of the first deficiencies to appear because the body’s magnesium stores are relatively small and depletion happens within weeks of inadequate intake.

Subclinical magnesium deficiency — the kind that doesn’t show up dramatically on a standard blood panel because serum magnesium is maintained at the expense of tissue stores — manifests as muscle cramps, poor sleep quality, heightened anxiety, restless legs, and impaired insulin sensitivity. Every one of these symptoms makes GLP-1 therapy harder. Cramps feel like the medication is causing muscle problems (it’s the magnesium). Poor sleep increases hunger hormones and reduces GLP-1 efficacy. Anxiety is often attributed to the lifestyle change rather than a correctable mineral deficiency.

Why glycinate specifically: The form matters more for magnesium than for almost any other mineral supplement.

• Magnesium oxide: cheapest, most common in drugstore supplements. Bioavailability is approximately 4% (Firoz & Graber, 2001, Journal of Clinical Pharmacology). You’d need to take enormous doses to achieve meaningful tissue levels, and the unabsorbed magnesium causes osmotic diarrhea. On a GLP-1, that’s unacceptable.
• Magnesium citrate: moderate bioavailability (~25%), but it has a well-known laxative effect at therapeutic doses. This is the form used in bowel prep. If your GI tract is already unpredictable from GLP-1 titration, adding a laxative-effect mineral is self-defeating.
• Magnesium glycinate (bisglycinate): ~50% bioavailability with minimal GI effect. The magnesium is chelated to glycine, which is absorbed through amino acid transport pathways rather than mineral channels, reducing the osmotic effect in the gut. This is the right form for GLP-1 patients.

Sleep timing is intentional: Glycine — the amino acid that glycinate is bound to — has independent sleep-promoting effects. A 2012 study (Bannai & Kawai, Frontiers in Neurology) demonstrated that glycine supplementation before bed improved subjective sleep quality, reduced sleep onset latency, and improved next-day cognitive performance. Taking magnesium glycinate at bedtime gets you two benefits from one supplement.

Dose: 200–400mg elemental magnesium. This is the critical detail that most people miss. Magnesium glycinate product labels list the weight of the compound (magnesium + glycine), not the elemental magnesium content. A capsule labeled “500mg magnesium glycinate” contains approximately 50mg of elemental magnesium. Read the supplement facts panel for “elemental magnesium” or “magnesium (as magnesium glycinate).” You want 200–400mg of that number. For most products, this means 4–8 capsules per day, which is why buying a product that lists elemental magnesium content clearly on the label saves confusion.

What to skip in Weeks 1–2

Protein supplements: You’re still figuring out what you can eat and when. Your stomach’s tolerance for volume and texture is changing day to day. Adding a whey shake to an already-nauseated stomach is a bad Week 1 decision. Wait until Week 3–4 when GI patterns have stabilized.

HMB: Valuable later in the protocol. Not valuable enough during titration to justify adding another GI variable. HMB can cause mild nausea in some people — indistinguishable from GLP-1 titration nausea.

Multivitamins: Actually reasonable to discuss, but hold for Weeks 3–4. Many multivitamins contain iron, zinc, and B vitamins that can cause nausea on an empty or sensitive stomach. Wait for GI stabilization.

Probiotics: The evidence for probiotics in GLP-1 therapy specifically is nonexistent. General gut health claims don’t transfer to a pharmacologically altered GI environment. Save your money until someone runs a trial.

Weeks 3–4: GI stabilization and protein strategy

By Week 3, most patients report that GI symptoms have become manageable or at least predictable. You know which foods sit well and which ones cause trouble. You have a sense of your eating windows. If GI symptoms are still severe and unpredictable at this point, that’s worth discussing with your prescriber — it may indicate that the titration schedule is too aggressive for your physiology.

Protein distribution strategy

This is not a supplement. It’s a restructuring of how you eat. But it belongs in this protocol because it is the single highest-leverage lean mass intervention available, and the timing — establishing it during Weeks 3–4, before the aggressive weight loss of Phase 2 — is deliberate.

The problem: GLP-1 patients eat small volumes. A 400–600 calorie meal is a realistic eating occasion. The issue is that when appetite is suppressed and food volume is limited, most people default to whatever sounds tolerable — and “tolerable” on a GLP-1 often means carb-forward foods with fast gastric emptying: crackers, toast, rice, fruit, soup. These foods go down easy. They don’t cause nausea. And they contain almost no protein.

The target: 30–40g protein per eating occasion, across 3–4 eating occasions per day. This target is based on the leucine threshold for muscle protein synthesis (MPS). MPS is an all-or-nothing signal triggered when intracellular leucine concentration crosses a threshold — approximately 2.5–3g of leucine per meal (Norton & Layman, 2006, Journal of Nutrition). Below the threshold, MPS doesn’t fire. Above it, it fires maximally. There’s no linear dose-response between these points. This means 20g of protein at a meal is dramatically less effective for muscle preservation than 30g, even though the difference is only 10 grams — because 20g is likely below the leucine threshold while 30g is above it.

Foods that work on a GLP-1 (high leucine, manageable volume):

• Greek yogurt: 15–20g protein per cup, high leucine content, cold (cold foods tend to be better tolerated during nausea), palatable texture. The single best GLP-1-friendly protein food.
• Cottage cheese: 25g protein per cup, easily digestible, cold, can be flavored. Some patients struggle with the texture — blend it smooth if needed.
• Eggs: 6g protein each, high leucine per gram, versatile preparation. Two eggs plus 1 cup Greek yogurt is a 30g protein meal in manageable volume.
• Whey protein in liquid form: 25–30g protein per scoop, fastest to consume, highest leucine density per gram of any protein source. When solid food is intolerable, a whey shake is the backup plan.
• Canned fish (tuna, sardines, salmon): 20–25g protein per can, shelf-stable, room temperature palatable, no preparation required. High leucine. Sardines add omega-3s.

Foods that don’t work as well:

• Protein bars: Often high in fat and fiber, which slow gastric emptying further. On a GLP-1, the stomach already empties slowly. Adding a dense, slow-digesting bar can sit for hours and cause bloating.
• Collagen protein: Essentially zero leucine. The amino acid profile is dominated by glycine, proline, and hydroxyproline. Will not trigger MPS. Should not be counted toward protein targets.
• Most plant proteins (except soy): Lower leucine per gram than animal proteins. Pea protein and rice protein can work in adequate amounts but require higher volume to reach the leucine threshold.

Vitamin D3 + K2 — 2,000–5,000 IU D3, 100–200mcg K2-MK7

Vitamin D deficiency is the most common micronutrient deficiency in developed nations. Estimates range from 40–70% of adults with suboptimal levels (Holick, 2007, NEJM). GLP-1-induced caloric restriction amplifies this because dietary vitamin D sources (fatty fish, fortified dairy, eggs) are consumed in lower quantities when total food intake drops by 40–60%.

Vitamin D matters for this protocol for two specific reasons beyond general health:

1. Muscle protein synthesis: Vitamin D receptors (VDR) are expressed in skeletal muscle tissue. Vitamin D deficiency is associated with reduced MPS signaling and accelerated muscle atrophy (Ceglia & Harris, 2013, Molecular Aspects of Medicine). Correcting deficiency doesn’t create a supraphysiological muscle-building effect — it removes a brake on normal anabolic function.

2. Insulin sensitivity: Vitamin D plays a role in insulin signaling and glucose metabolism. Several meta-analyses associate vitamin D deficiency with impaired insulin sensitivity (Song et al., 2013, Diabetes Care). Since metabolic health improvement is a primary goal of GLP-1 therapy, ensuring adequate vitamin D supports that trajectory.

Why K2-MK7 is included: Vitamin D increases calcium absorption from the gut. At higher supplemental doses (4,000–5,000 IU/day), this means more circulating calcium. Vitamin K2 (menaquinone-7) activates osteocalcin and matrix GLA protein, which direct calcium into bone tissue rather than soft tissues and arterial walls. The evidence for K2 preventing vascular calcification from vitamin D supplementation is mechanistically sound and supported by observational data, though large RCTs are still limited. Given that K2-MK7 is inexpensive and safe, it’s included as a prudent addition rather than a strongly proven requirement.

Test first if possible. Ask your prescriber for a 25-hydroxy vitamin D level on your next blood draw. Target: 40–60 ng/mL. If you’re at 20 ng/mL (common), you may need 5,000 IU/day for 8–12 weeks to correct the deficit before dropping to a 2,000 IU maintenance dose. If you’re already at 45 ng/mL, 2,000 IU is appropriate maintenance. Dosing to your actual level is more efficient and safer than a fixed dose for everyone.

Month 2: The core lean mass protocol

You’ve reached or are approaching your therapeutic dose. Weight loss is accelerating. GI symptoms have stabilized enough that you know your tolerance profile. This is the month where body composition outcomes are determined — and the month where most people need to add the remaining core interventions.

HMB (beta-hydroxy beta-methylbutyrate) — 3g daily in divided doses

HMB is a metabolite of leucine that acts through the ubiquitin-proteasome pathway — the primary cellular mechanism for breaking down muscle protein. Leucine is metabolized to alpha-ketoisocaproate (KIC), which is then metabolized to HMB. Only about 5% of dietary leucine ends up as HMB, which is why supplementation provides concentrations that diet alone cannot achieve.

Why Month 2 and not Week 1: HMB’s primary mechanism — inhibiting proteolytic (muscle-breakdown) pathways — is most relevant when muscle protein breakdown is elevated. During mild caloric restriction in Weeks 1–4, breakdown is modestly elevated. During the aggressive deficit of Months 2–6, breakdown is significantly elevated. Adding HMB earlier doesn’t harm anything, but the risk-benefit calculation (additional GI variable during titration vs. modest anti-catabolic benefit during mild deficit) favors waiting.

Dosing protocol: 1g three times daily, ideally with meals. The pharmacokinetics of HMB matter here — it has a relatively short half-life (~2.5 hours for the calcium salt form), and its anti-catabolic effect is most valuable between meals when amino acid levels drop and proteolysis increases. Dividing the dose ensures more consistent tissue levels throughout the day. If three-times-daily dosing is impractical, 1.5g twice daily is an acceptable compromise.

The evidence — honestly assessed: The most-cited study is Wilson et al. (2014, Journal of the International Society of Sports Nutrition). In a 4-week aggressive caloric restriction protocol combined with heavy resistance training, the HMB-free acid group preserved 100% of lean mass (mean change: 0.0 kg) while the placebo group lost 1.5 kg of lean mass. The HMB group also lost significantly more fat mass. These are striking numbers.

The caveat: this study was funded by industry (Abbott/EAS, which manufactures HMB supplements). The Wilson research group has received consistent industry funding for HMB research. This doesn’t invalidate the findings, but it requires noting. The anti-catabolic effect of HMB has been replicated in other labs — a meta-analysis by Wu et al. (2015, British Journal of Nutrition) confirmed a statistically significant lean mass preservation effect — but at more modest effect sizes than the Wilson headline numbers. Evidence grade: Moderate to Strong, with the “strong” end coming predominantly from industry-funded work.

HMB-free acid vs. HMB-calcium: HMB-FA (free acid) has faster absorption and higher peak blood levels. HMB-Ca (calcium salt) is more widely available and cheaper. The Wilson study used HMB-FA. Most commercial products are HMB-Ca. Both work. If you can find HMB-FA at a reasonable price, it’s marginally better. If not, HMB-Ca at 3g/day is the standard and well-supported dose.

Cost note: HMB is not cheap — expect $0.50–$1.50 per day depending on form and brand. If budget is a constraint, creatine is more cost-effective per unit of lean mass preserved (roughly $0.05–0.10/day for creatine monohydrate vs. $0.50–1.50/day for HMB). HMB is an add-on to creatine, not a replacement. If you can only afford one, choose creatine.

Resistance training — 2 sessions per week minimum

This is not a supplement. But it belongs in the Month 2 protocol section because it is the single most powerful lean mass preservation intervention available — more powerful than any supplement, any protein strategy, or any pharmaceutical. And Month 2 is when the lean mass risk is highest, making this the most critical time to have an established resistance training habit.

Program requirements: Compound movements that load large muscle groups through full ranges of motion. At minimum, your twice-weekly sessions should include:

• A squat pattern (barbell squat, goblet squat, leg press)
• A hip hinge pattern (Romanian deadlift, conventional deadlift, hip thrust)
• A horizontal push (bench press, push-up, dumbbell press)
• A horizontal pull (barbell row, dumbbell row, cable row)
• A vertical pull (pull-up, lat pulldown, chin-up)

You don’t need a gym. A pair of adjustable dumbbells and a pull-up bar cover every pattern. Goblet squats, Romanian deadlifts with dumbbells, single-arm rows, push-ups, and a doorframe pull-up bar constitute a complete program.

The minimum effective dose: Two working sets per muscle group per session, twice per week. That’s four total weekly sets per muscle group. This is not an optimal hypertrophy program — optimal is 10–20 sets per muscle group per week. This is the minimum to send a “preserve this tissue” signal to your body during aggressive caloric restriction. The difference between zero sets and four sets per week is enormous. The difference between four sets and twenty is meaningful but much smaller when you’re in a deficit.

What progressive overload looks like on a GLP-1: You will likely be tired. You may be eating 1,000–1,200 calories. You are not going to set personal records. The goal is narrower than that: week over week, either perform more reps with the same weight, or perform the same reps with slightly more weight. This progression — however small — is evidence that you’re maintaining the training stimulus that signals muscle preservation. If your numbers are holding steady, your muscle is likely holding steady. If your numbers are declining week over week for three or more weeks, something needs to change — check protein intake first, then consider whether the deficit is too aggressive for your recovery capacity.

Timing relative to HMB introduction: Start resistance training and HMB in the same phase, but ideally not the same day. Begin training at the start of Month 2. Add HMB one week later. This way, if you experience any GI issues from HMB, you can distinguish them from the general fatigue of starting a training program.

Month 2+: Advanced additions for specific problems

Everything above this section is the core protocol — recommended for essentially all GLP-1 patients. Everything below is conditional. Add based on your actual situation, your actual lab values, and your actual symptoms. Not because it’s on the list.

Leucine powder — if protein distribution is consistently failing

If you are genuinely unable to hit 30g protein per eating occasion despite intentional food selection — due to severe appetite suppression, gastroparesis, or food aversions — adding 3–5g of leucine powder to smaller meals can partially compensate the MPS signaling gap.

The mechanism is straightforward: MPS initiation is gated primarily by intracellular leucine concentration. If a meal provides 15g of protein (below the leucine threshold), adding 3g of supplemental leucine may push total leucine above the threshold and trigger MPS. This is not ideal. Leucine alone, without the full complement of essential amino acids, provides a weaker and shorter-duration MPS signal than adequate whole protein (Churchward-Venne et al., 2012, Journal of Physiology). Think of it as a partial credit solution — better than chronically missing the threshold, but not as good as actually eating enough protein.

Practical considerations: Leucine powder is aggressively bitter. Mixing it into water is an unpleasant experience. Mix it into a protein shake, stir it into Greek yogurt, or blend it into a smoothie where other flavors can mask the bitterness. Capsule form exists but requires swallowing 6–10 capsules to reach 3g, which may not be practical.

When to use this vs. just adding whey protein: If you can tolerate a whey protein shake, that’s better — it provides leucine plus all other essential amino acids. Leucine supplementation is specifically for situations where even a protein shake is too much volume or too nauseating, and you’re supplementing smaller, tolerable meals that fall short of the leucine threshold on their own.

Zinc + copper — if hair loss is occurring

Telogen effluvium — diffuse hair shedding that typically starts 2–4 months after a physiological stressor — is one of the most distressing side effects reported by GLP-1 patients. It is not a GLP-1-specific side effect. It is a caloric-restriction side effect that GLP-1 therapy amplifies because the restriction is deeper and more sustained than typical dieting.

The hair growth cycle includes a growth phase (anagen), a regression phase (catagen), and a resting phase (telogen). Physiological stress — including rapid weight loss and micronutrient deficiency — shifts a disproportionate number of follicles from anagen into telogen simultaneously. Two to four months later, those follicles release their hairs and the shedding becomes visible. This is why hair loss appears to “start” months after beginning GLP-1 therapy even though the follicular shift happened much earlier.

Zinc deficiency contributes to telogen effluvium through multiple mechanisms: impaired keratin synthesis, reduced cell division in the hair follicle matrix, and altered immune function affecting follicular health. GLP-1-induced caloric restriction commonly creates zinc deficiency because zinc-rich foods (red meat, shellfish, legumes) are often consumed in reduced quantities.

Dose: Zinc 25–50mg/day (as zinc picolinate or zinc bisglycinate for best absorption). Add copper 2mg/day whenever supplementing zinc above 25mg — zinc and copper compete for absorption at the same transporter, and chronic zinc supplementation without copper causes copper deficiency over time. Copper deficiency causes its own set of problems (anemia, neutropenia, neurological symptoms) that are entirely avoidable by co-supplementing.

Timeline expectation: Hair has a long growth cycle. Even if you correct the zinc deficiency immediately, existing telogen hairs will continue to shed until the follicle re-enters anagen. Expect 3–6 months before visible improvement. This is not the supplement failing — it’s the biology of hair growth.

Omega-3 EPA/DHA — 2–4g combined EPA+DHA daily

Omega-3 fatty acids have documented anti-catabolic properties during caloric restriction. Smith et al. (2015, American Journal of Clinical Nutrition) demonstrated that EPA+DHA supplementation reduced muscle protein breakdown during a controlled caloric deficit in a small RCT. The effect size was modest but statistically significant. The proposed mechanism involves EPA’s influence on the ubiquitin-proteasome and autophagy-lysosome proteolytic pathways — the same pathways HMB targets, through a different mechanism.

Beyond muscle preservation, omega-3 supplementation during GLP-1 therapy offers secondary benefits:

• Lipid profile optimization: GLP-1 therapy already improves lipid profiles for most patients. Omega-3s (particularly EPA) further reduce triglycerides, supporting the cardiometabolic benefits of therapy.
• Systemic inflammation: Rapid weight loss is paradoxically pro-inflammatory. Adipose tissue releases inflammatory cytokines during lipolysis. Omega-3s modulate this inflammatory response.
• Mood and cognition: EPA has documented antidepressant effects at doses above 1g/day (Sublette et al., 2011, Journal of Clinical Psychiatry). Given that GLP-1 therapy involves significant lifestyle disruption and caloric restriction (both associated with mood changes), this is a relevant secondary benefit.

Dose specificity matters: The label says “fish oil 1000mg” but the relevant number is combined EPA+DHA, which is often only 300mg per capsule. You need the combined EPA+DHA number to be 2–4g. For most standard fish oil capsules, that means 7–13 capsules per day, which is impractical. Buy a concentrated fish oil product that provides 700–1,000mg combined EPA+DHA per capsule, reducing the daily count to 2–4 capsules. Liquid fish oil (flavored) is another option that avoids the capsule-count problem entirely.

GI note: Fish oil can cause fishy burps and mild GI discomfort, particularly on a GLP-1-altered stomach. Taking with food and using enteric-coated capsules reduces this. If GI side effects are problematic, algal oil (vegan omega-3 from microalgae) provides DHA with fewer GI side effects, though EPA content is typically lower.

What to skip entirely

Knowing what not to take is as valuable as knowing what to take. Every unnecessary supplement adds GI load, cognitive load (another thing to remember), and financial cost. These are specifically not recommended for a GLP-1 support protocol.

Collagen protein supplements

Collagen is one of the most heavily marketed supplements in the wellness space, with claims ranging from improved skin elasticity to joint health to gut healing. The issue isn’t that collagen doesn’t do anything — there is modest evidence for skin hydration effects. The issue is that collagen is being marketed to GLP-1 patients as a protein supplement, and as a protein supplement, it is one of the worst options available.

Collagen’s amino acid profile is dominated by glycine (~33%), proline (~13%), and hydroxyproline (~10%). Leucine content is essentially zero. Per 20g serving of collagen peptides, you get approximately 0g of leucine — the amino acid that triggers muscle protein synthesis. Compare this to 20g of whey protein, which provides roughly 2.5g of leucine. Collagen will not trigger MPS. It should not be counted toward your protein targets for muscle preservation purposes.

If you’re taking collagen for skin or joint reasons, that’s a separate decision — but don’t confuse it with a protein supplement, and don’t let it displace actual protein in your diet. Twenty grams of collagen instead of twenty grams of whey is a meaningful loss in your daily leucine budget.

Commercial “GLP-1 support” stacks

Products ranging from $80 to $150 per month that combine some configuration of berberine, chromium picolinate, alpha-lipoic acid, bitter melon extract, gymnema sylvestre, and various B vitamins. The marketing pitch: these ingredients “support your body’s natural GLP-1 response” or “enhance GLP-1 effectiveness.”

The reality: each of these ingredients has weak-to-moderate evidence for glucose management in non-medicated populations. Berberine has the strongest evidence — it modestly reduces HbA1c in people not taking diabetes medications (Liang et al., 2019, Journal of Ethnopharmacology). But you are already taking a pharmaceutical-grade GLP-1 receptor agonist. Semaglutide reduces HbA1c by 1.5–2.0 percentage points. Berberine reduces it by 0.5 percentage points in unmedicated patients. The incremental benefit of adding berberine on top of semaglutide has not been studied because it is pharmacologically implausible that it would matter.

These stacks are not harmful (mostly). They are expensive, pharmacologically redundant, and they add pill burden and GI load without demonstrated benefit for someone already on GLP-1 therapy. The money is better spent on creatine, HMB, and high-quality protein sources.

BCAA supplements

Branched-chain amino acids — leucine, isoleucine, and valine — were a staple of bodybuilding supplementation in the 1990s and 2000s. The rationale was that BCAAs in isolation could stimulate muscle protein synthesis and reduce muscle breakdown.

The subsequent research has clarified the picture: leucine is the active ingredient. Isoleucine and valine do not independently stimulate MPS. And supplementing leucine alone (or through adequate dietary protein) is more efficient than supplementing all three BCAAs. If you’re hitting your protein targets with leucine-rich foods, BCAAs are completely redundant — you’re already getting abundant BCAAs from food protein. If you’re not hitting your protein targets, BCAAs alone won’t fix the problem because MPS requires all essential amino acids, not just the three branched-chain ones (Wolfe, 2017, Journal of the International Society of Sports Nutrition).

Save the money. Put it toward whey protein or actual food.

Fat burners and thermogenics

You are on a GLP-1 receptor agonist that reduces caloric intake by 25–40%. You do not need a thermogenic supplement to increase energy expenditure by 50–100 calories per day. The risk-to-benefit ratio is unfavorable: most thermogenics contain caffeine and/or synephrine, which increase heart rate and blood pressure. GLP-1 agonists at higher doses have their own modest heart rate effects (an increase of 2–4 bpm is commonly reported in trials). Stacking stimulants on top of GLP-1 therapy is pharmacologically redundant for fat loss and potentially concerning for cardiovascular parameters.

If you want the energy boost from caffeine, drink coffee. Don’t buy a fat burner.

Tracking and adjusting

A protocol without measurement is just a wish. Here’s how to verify that what you’re doing is actually working — and when to change course.

Body composition measurement

Gold standard: DEXA scan. Get a baseline before or within the first month of GLP-1 therapy, then repeat at 3 months and 6 months. DEXA gives you fat mass, lean mass, and bone density — the three numbers that tell the real story of your weight loss. Cost is typically $75–150 per scan at outpatient imaging centers. This is the single best investment in knowing whether your protocol is working.

Accessible alternative: bioimpedance analysis. InBody, Tanita, and similar scales estimate body composition using electrical impedance. They are less accurate than DEXA in absolute terms but reasonably consistent for tracking trends over time — provided you use the same device, at the same time of day, in the same hydration state. The number itself might be off by 3–5%, but the direction of change (gaining lean mass, losing lean mass, stable lean mass) is directionally reliable.

Not useful: bathroom scale alone. Total body weight tells you almost nothing about body composition. You can lose 10 pounds of muscle and 10 pounds of fat and the scale says you lost 20 pounds — which sounds great until you realize half of it was the tissue you wanted to keep.

Performance proxy

Your strength numbers in resistance training are a real-time readout of muscle function. If your squat, deadlift, row, and press numbers are holding steady or slowly increasing over weeks, your lean mass is almost certainly being preserved. If they’re declining for three or more consecutive weeks, something is wrong — check protein intake first, then sleep, then consider whether the caloric deficit is too aggressive for your recovery capacity.

Track your working weights and rep counts. A simple notebook or phone note is sufficient. You don’t need an app.

Periodic protein verification

Track your food intake for one full week every 4–6 weeks. Not forever — chronic food tracking creates its own psychological burden, especially on a GLP-1 where your relationship with food is already changing. But a periodic check is essential because most people overestimate their protein intake by 20–30%.

During your tracking week, pay attention to: total daily protein (target: 1.6g per kg bodyweight minimum), leucine per eating occasion (target: 2.5–3g, roughly equivalent to 30g of animal protein per meal), and protein distribution across meals (avoid loading all your protein into one meal — MPS is triggered per-meal, so three 35g meals beat one 100g meal for muscle preservation).

Blood work

Baseline metabolic panel at the start of GLP-1 therapy, then repeat at 3 months. Key markers to watch:

• eGFR and creatinine: Remember the creatine context. If creatinine is elevated by 10–20% from baseline and you’re taking creatine, this is expected and not concerning. Flag it for your prescriber.
• Magnesium: Serum magnesium is a poor marker of total body magnesium (it’s maintained at the expense of tissue stores), but a low serum level definitively indicates deficiency. A normal serum level does not rule out subclinical deficiency.
• 25-OH Vitamin D: Target 40–60 ng/mL. Adjust supplementation dose based on results.
• CBC (complete blood count): Monitors for iron deficiency anemia, which can develop during prolonged caloric restriction.

When to adjust the protocol

If you’re not hitting 1.6g/kg protein despite intentional effort: Consider liquid protein sources (whey concentrate mixed in water, ready-to-drink protein shakes), which are faster to consume and often better tolerated than solid protein. If even liquid protein is difficult, leucine supplementation (3–5g per meal) as a partial bridge until appetite allows adequate food intake.

If strength numbers decline for 3+ consecutive weeks: First verify protein intake. If protein is adequate, evaluate sleep quality and stress. If both are adequate, the caloric deficit may be too aggressive — discuss dose or titration pace with your prescriber.

If hair loss is significant by Month 3: Add zinc 25–50mg + copper 2mg daily. Set a 3–6 month timeline for evaluation. Consider a ferritin level check as well — iron deficiency is an independent contributor to telogen effluvium and common in caloric restriction.

If GI symptoms return after being stable: First rule out dietary causes (new food, larger meal size). If GI symptoms correlate with a recently added supplement, remove that supplement for one week and see if symptoms resolve. Reintroduce at half dose if they do.

The full protocol at a glance

Timeline	Intervention	Dose	Rationale
Week 1	Creatine monohydrate	3–5g/day	Begin saturation for lean mass protection
Week 1	Magnesium glycinate	200–400mg elemental, before bed	Prevent deficiency, improve sleep
Weeks 3–4	Protein distribution strategy	30–40g protein per eating occasion	Cross leucine threshold for MPS at each meal
Weeks 3–4	Vitamin D3 + K2-MK7	2,000–5,000 IU D3 + 100–200mcg K2	Correct deficiency, support MPS signaling
Month 2	HMB	3g/day in divided doses (1g x 3)	Anti-catabolic during peak weight loss
Month 2	Resistance training	2x/week, compound movements	Strongest lean mass preservation signal
Month 2+ (conditional)	Leucine powder	3–5g per meal if protein targets unmet	Partial MPS rescue for inadequate meals
Month 2+ (conditional)	Zinc + copper	25–50mg zinc + 2mg copper	If hair loss (telogen effluvium) occurs
Month 2+ (conditional)	Omega-3 EPA/DHA	2–4g combined EPA+DHA	Anti-catabolic, lipid support, anti-inflammatory

Always skip: collagen protein (zero leucine, does not support MPS), BCAA supplements (redundant if protein is adequate), commercial “GLP-1 support” stacks (pharmacologically redundant), fat burners and thermogenics (unnecessary and potentially concerning with GLP-1 heart rate effects).

A note on sourcing

leanloss.com carries the core stack — creatine monohydrate, HMB, and magnesium glycinate — if you prefer a single-source option with products specifically selected for GLP-1 patients. Affiliate disclosure: glp.health has a commercial relationship with leanloss.com. The protocol above is evidence-based and brand-agnostic — buy from whoever you trust. The interventions work regardless of source.

References

• Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Frontiers in Neurology. 2012;3:61.
• Ceglia L, Harris SS. Vitamin D and its role in skeletal muscle. Molecular Aspects of Medicine. 2013;34(6):953-959.
• Churchward-Venne TA, et al. Supplementation of a suboptimal protein dose with leucine or essential amino acids. Journal of Physiology. 2012;590(11):2751-2765.
• Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Journal of Clinical Pharmacology. 2001;19(4):321-326.
• Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266-281.
• Hultman E, et al. Muscle creatine loading in men. Journal of Applied Physiology. 1996;81(1):232-237.
• Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.
• Liang Y, et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus. Journal of Ethnopharmacology. 2019;234:220-229.
• Norton LE, Layman DK. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. Journal of Nutrition. 2006;136(2):533S-537S.
• Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States. Nutrition Reviews. 2012;70(3):153-164.
• Safdar A, et al. Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation. PLOS One. 2008;3(3):e1547.
• Smith GI, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. American Journal of Clinical Nutrition. 2015;102(1):115-122.
• Song Y, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes. Diabetes Care. 2013;36(5):1422-1428.
• Sublette ME, et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry. 2011;72(12):1577-1584.
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
• Wilson JM, et al. The effects of 12 weeks of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, strength, and power. Journal of the International Society of Sports Nutrition. 2014;11(1):1-14.
• Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? Journal of the International Society of Sports Nutrition. 2017;14(1):30.
• Wu H, et al. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. British Journal of Nutrition. 2015;114(10):1523-1531.